Since ngTASO exclusively acts on the human TGF-β2 mRNA sequence, it is considered that downregulation of the tumor-derived TGF-β2 by ngTASO might primarily contribute to the reduction of intrinsic active β-catenin in xenografted A2058 tumors. The gene discussed is TGFB2; the disease is neoplasm.